The COVID-19 Pandemic and Enzyme Replacement Therapy in Lysosomal Storage Disorders
Aim:The coronavirus disease-2019 (COVID-19) pandemic has caused a worldwide public health emergency, especially affecting people with chronic illnesses including lysosomal storage disorders (LSDs). The unfavorable conditions due to COVID-19 have mostly affected people with chronic conditions, in ter...
Saved in:
Main Authors: | Asburçe Olgaç (Author), Çiğdem Seher Kasapkara (Author), Burak Açıkel (Author), Yılmaz Yıldız (Author), Gülhan Karakaya Molla (Author), Mustafa Kılıç (Author) |
---|---|
Format: | Book |
Published: |
Galenos Yayinevi,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
by: María Dolores Edo-Solsona, et al.
Published: (2020) -
The Evaluation of Skeletal Manifestations in Patients with Gaucher Disease
by: Çiğdem Seher Kasapkara, et al.
Published: (2021) -
Lysosomal acid lipase deficiency: analysis of enzyme replacement therapy
by: N.A. Polyanskaya, et al.
Published: (2022) -
Unsheathing new insights into lysosomal storage disorders
by: Kirsty M. Hooper
Published: (2023) -
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Published: (2021)